Tag: TLX

Telix Pharmaceuticals ASX TLX phase two prostate cancer imaging study GenesisCare

Telix Pharmaceuticals to begin phase two prostate cancer imaging study

Biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has been given the green light to commence a phase two study involving its medical imaging technology on...
Telix Pharmaceuticals ASX TLX prostate cancer imaging technology

Telix Pharmaceuticals partners with Mexican nuclear science firm to advance prostate imaging technology

Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has completed an in-licensing agremeent with Mexico’s Instituto Nacional de Investigaciones Nucleares (ININ) for a clinical-stage radiopharmaceutical...
Telix Pharmaceuticals ASX TLX Advanced Nuclear Medicine Ingredients

Telix Pharmaceuticals acquires Belgium-based Advanced Nuclear Medicine Ingredients

Telix Pharmaceuticals (ASX: TLX) has made a play for Belgium company Advanced Nuclear Medicine Ingredients, with the takeover valuing ANMI at over £5.15 million...
Telix Pharmaceuticals ASX TLX phase 3 trial recruitment renal cell carcinoma RCC zirconium imaging oncology ZIRCON Australia

Telix Pharmaceuticals readies recruitment for phase 3 trial in renal cancer

Melbourne-based biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is preparing to commence recruitment for its zirconium imaging in renal cancer oncology (ZIRCON) phase 3 trial...
Telix Pharmaceuticals ASX TSX cancer treatment GenesisCare

Telix Pharmaceuticals strikes cancer treatment access deal with GenesisCare

Biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has teamed up with the largest private provider of oncology services in Australia and Europe, GenesisCare, to accelerate...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS